Do you take your blood thinner every day? new study aims to find out
NCT ID NCT05469308
First seen Jun 13, 2026 · Last updated Jun 22, 2026 · Updated 1 time
Summary
This study tracked 883 adults with atrial fibrillation to see how faithfully they took their direct oral anticoagulants (blood thinners). Researchers used pharmacy refill records and questionnaires to measure adherence. The goal is to create a profile of patients at risk of skipping doses, so pharmacists can step in to help.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADHERENCE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Amiens
Amiens, 80480, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help identify patients who are likely to skip their blood thinners, allowing pharmacists to offer extra support and reduce stroke risk.
What could go wrong
This is an observational study, not a treatment trial. It only measures adherence, so it cannot prove that any intervention improves outcomes. Results may not apply to all patient groups.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.